title: [Evaluation of the therapeutic activity of and gastric lesions due to new NSAID versus placebo in patients with osteoarticular diseases].
abstract: Oral amtolmetineguacyl 600 mg/day in a single blind comparative trial with placebo carried out in 24 patients suffering from rheumatic disorders of varying severity, reduced statistically all the symptomatology correlated to inflammation. Moreover our results indicate a lack of any gastric problem even in patient with a previous history of intolerance to other NSAIDs.
authors.affiliation: Dipartimento di Medicina Clinica, Università degli Studi di Roma La Sapienza.
authors.forename: M
authors.initials: M
authors.lastname: Delfino
authors.forename: D
authors.initials: D
authors.lastname: Klesczynski
authors.forename: A
authors.initials: A
authors.lastname: Iannetti
authors.forename: C
authors.initials: C
authors.lastname: Valente
authors.forename: E
authors.initials: E
authors.lastname: Alicicco
mesh_terms: D000368:Aged; D000893:Anti-Inflammatory Agents / Q000009:adverse effects* / Q000494:pharmacology / Q000627:therapeutic use*; D005753:Gastric Mucosa / Q000187:drug effects / Q000503:physiopathology; D005767:Gastrointestinal Diseases / Q000209:etiology* / Q000503:physiopathology; D006801:Humans; D008875:Middle Aged; D010003:Osteoarthritis / Q000188:drug therapy*; D010919:Placebos; D013256:Steroids
chemical_list: D000893:Anti-Inflammatory Agents; D010919:Placebos; D013256:Steroids
vernacular_title: Valutazione dell'attività terapeutica e della gastrolesività di un nuovo FANS in confronto a placebo in pazienti con patologie osteoarticolari.